MiNK Therapeutics INKT
NASDAQ INKT
$12.26 +0.15 (+1.24%)
At close: Sep 29, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Share-based Compensation (2020 - 2026)

Updated

MiNK Therapeutics' Share-based Compensation was $422,202 in Q2 2026, down 52.9% from $896,552 a year earlier and down 33.0% from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Share-based Compensation (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, MiNK Therapeutics' Share-based Compensation was $2.24 million through Jun 30, 2026, down 1.3% year-over-year; for FY2025, it came in at $2.67 million, up 47.7% from FY2024.

  • Share-based Compensation shows a five-year compound annual growth rate of 98.0% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $1.81 million in FY2024 (-53.1%), $3.86 million in FY2023 (+27.5%), $3.03 million in FY2022 (+73.5%) and $1.74 million in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Share-based Compensation since Q4 2024.
  • Compared with a year earlier, Share-based Compensation was higher in four of the last eight quarters, with growth averaging 4.9%.
  • The best year-over-year quarter for Share-based Compensation over five years was Q1 2022 (growth of 177.5%); the worst was Q4 2024 (a decline of 64.6%).
  • Per Business Quant data, INKT's Share-based Compensation in the three quarters before Q2 2026 was $630,386 (Q1 2026), $565,771 (Q4 2025) and $620,585 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 MiNK Therapeutics 61.82 Mn 61.82 Mn - 422,202.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 422,202.00
Mar 31, 2026 630,386.00
Dec 31, 2025 565,771.00
Sep 30, 2025 620,585.00
Jun 30, 2025 896,552.00
Mar 31, 2025 591,089.00
Dec 31, 2024 390,048.00
Sep 30, 2024 391,298.00
Jun 30, 2024 436,874.00
Mar 31, 2024 592,006.00
Dec 31, 2023 1.10 Mn
Sep 30, 2023 939,264.00
Jun 30, 2023 898,265.00
Mar 31, 2023 921,139.00
Dec 31, 2022 667,631.00
Sep 30, 2022 772,899.00
Jun 30, 2022 800,810.00
Mar 31, 2022 785,506.00
Dec 31, 2021 667,029.00
Sep 30, 2021 387,362.00
API Access

MiNK Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INKT&period=max&api_key=YOUR_API_KEY